Leading up to the publication of the Evaluate Vantage 2022 Preview, we created this Infographic to provide a snapshot of the products and companies that are driving top line growth in the biopharma sector, key financial market trends, and the challenges and opportunities that lie ahead.
Share:
Leading up to the publication of the Evaluate Vantage 2022 Preview, we created this Infographic to provide a snapshot of the products and companies that are driving top line growth in the biopharma sector, key financial market trends, and the challenges and opportunities that lie ahead.
By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.
